ONTX - Onconova Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
2,212
1,228
787
5,546
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
15,782
16,924
19,119
20,071
Selling General and Administrative
8,548
7,586
7,405
9,178
Total Operating Expenses
24,330
24,510
26,524
29,249
Operating Income or Loss
-22,118
-23,282
-25,737
-23,703
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
587
2,748
1,658
4,050
Income Before Tax
-21,531
-20,534
-24,079
-19,653
Income Tax Expense
-
-124
13
14
Income from Continuing Operations
-21,407
-20,410
-24,092
-19,667
Net Income
-21,407
-20,573
-24,092
-19,667
Net Income available to common shareholders
-21,407
-20,573
-24,092
-19,667
Reported EPS
Basic
-
-4.99
-40.20
-66.60
Diluted
-
-4.99
-40.20
-66.60
Weighted average shares outstanding
Basic
-
4,124
600
295
Diluted
-
4,124
600
295
EBITDA
-
-23,227
-25,649
-23,607